Charles Schwab Investment Management Inc Annexon, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 181,051 shares of ANNX stock, worth $887,149. This represents 0.0% of its overall portfolio holdings.
Number of Shares
181,051
Previous 123,668
46.4%
Holding current value
$887,149
Previous $561,000
131.37%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ANNX
# of Institutions
138Shares Held
87.3MCall Options Held
2.54MPut Options Held
556K-
Bain Capital Life Sciences Investors, LLC Boston, MA8.7MShares$42.6 Million9.43% of portfolio
-
Satter Management Co., L.P.7.41MShares$36.3 Million59.29% of portfolio
-
Bvf Inc San Francisco, CA7MShares$34.3 Million1.5% of portfolio
-
Redmile Group, LLC San Francisco, CA5.5MShares$27 Million1.56% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.16MShares$25.3 Million0.09% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $233M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...